OCS: Oculis Holding AG Stock

by  •  • Comments Off on OCS: Oculis Holding AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 501.88
Enterprise Value ($M) n/a
Book Value ($M) 93.73
Book Value / Share 2.25
Price / Book n/a
NCAV ($M) 80.39
NCAV / Share 1.93
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.94
Return on Assets (ROA) -2.40
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.29
Current Ratio 5.29

Balance Sheet (mrq) ($M)
Current Assets 101.02
Assets 114.35
Liabilities 20.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.88
Operating Income -45.85
Net Income -88.80

Cash Flow Statement (mra) ($M)
Cash From Operations -53.84
Cash from Investing -54.21
Cash from Financing 129.67

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Novartis Bioventures Ltd 4.70 -21.32
02-12 13G/A Pivotal bioVenture Partners Fund I, L.P. 7.40 -20.36
02-09 13G LSP 7 Cooperative UA 14.60
05-04 13G Brunnur vaxtarsjodur slhf 7.10
05-02 13G Bvcf Iv, L.p. 6.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 13,102 88,399 14.82
2024-04-25 1,718 2,091 82.16
2024-04-24 2,555 95,912 2.66
2024-04-23 6,211 116,047 5.35
2024-04-22 5,085 37,679 13.50

(click for more detail)

Similar Companies
NKGN – NKGen Biotech, Inc. NRIX – Nurix Therapeutics, Inc.
NTLA – Intellia Therapeutics, Inc. OCUL – Ocular Therapeutix, Inc.
OMER – Omeros Corporation


Financial data and stock pages provided by
Fintel.io